](https://i.ytimg.com/vi/bHabcAgvFSg/maxresdefault.jpg)
A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.
4 Просмотры
• 07/10/23
0
0
встраивать
administrator
Подписчики
A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.
Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии